The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with Type 2 diabetes
Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima‐media thickness in patients with Type 2 diabetes mellitus. Methods...
Saved in:
Published in | Diabetic medicine Vol. 30; no. 2; pp. e41 - e50 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.02.2013
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective
Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima‐media thickness in patients with Type 2 diabetes mellitus.
Methods
One hundred patients with Type 2 diabetes were equivalently (n = 25) randomized into four groups: (1) a control group with patients encouraged to perform self‐controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60–75% of maximum heart rate); (3) a resistance training group (60–80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA1c levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima‐media thickness measurements were obtained at baseline and at the end of the study, after 6 months.
Results
At baseline, there were non‐significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group (P < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups (P < 0.05). Moreover, high‐sensitivity C‐reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups (P < 0.05). Within‐ and between‐group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima‐media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake.
Conclusions
In subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima‐media thickness progression. |
---|---|
AbstractList | Objective
Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima‐media thickness in patients with Type 2 diabetes mellitus.
Methods
One hundred patients with Type 2 diabetes were equivalently (n = 25) randomized into four groups: (1) a control group with patients encouraged to perform self‐controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60–75% of maximum heart rate); (3) a resistance training group (60–80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA1c levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima‐media thickness measurements were obtained at baseline and at the end of the study, after 6 months.
Results
At baseline, there were non‐significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group (P < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups (P < 0.05). Moreover, high‐sensitivity C‐reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups (P < 0.05). Within‐ and between‐group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima‐media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake.
Conclusions
In subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima‐media thickness progression. Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima-media thickness in patients with Type 2 diabetes mellitus. Methods One hundred patients with Type 2 diabetes were equivalently (n = 25) randomized into four groups: (1) a control group with patients encouraged to perform self-controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60-75% of maximum heart rate); (3) a resistance training group (60-80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA1c levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima-media thickness measurements were obtained at baseline and at the end of the study, after 6 months. Results At baseline, there were non-significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group (P < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups (P < 0.05). Moreover, high-sensitivity C-reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups (P < 0.05). Within- and between-group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima-media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake. Conclusions In subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima-media thickness progression. [PUBLICATION ABSTRACT] Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima-media thickness in patients with Type 2 diabetes mellitus. One hundred patients with Type 2 diabetes were equivalently (n = 25) randomized into four groups: (1) a control group with patients encouraged to perform self-controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60-75% of maximum heart rate); (3) a resistance training group (60-80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA(1c) levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima-media thickness measurements were obtained at baseline and at the end of the study, after 6 months. At baseline, there were non-significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group (P < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups (P < 0.05). Moreover, high-sensitivity C-reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups (P < 0.05). Within- and between-group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima-media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake. In subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima-media thickness progression. Abstract Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima‐media thickness in patients with Type 2 diabetes mellitus. Methods One hundred patients with Type 2 diabetes were equivalently ( n = 25) randomized into four groups: (1) a control group with patients encouraged to perform self‐controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60–75% of maximum heart rate); (3) a resistance training group (60–80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA 1c levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima‐media thickness measurements were obtained at baseline and at the end of the study, after 6 months. Results At baseline, there were non‐significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group ( P < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups ( P < 0.05). Moreover, high‐sensitivity C‐reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups ( P < 0.05). Within‐ and between‐group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima‐media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake. Conclusions In subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima‐media thickness progression. OBJECTIVEAdipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise modalities on the aforementioned novel adipokines and carotid intima-media thickness in patients with Type 2 diabetes mellitus.METHODSOne hundred patients with Type 2 diabetes were equivalently (n = 25) randomized into four groups: (1) a control group with patients encouraged to perform self-controlled exercise; (2) a supervised aerobic exercise group (exercise four times/week, 60 min/session, 60-75% of maximum heart rate); (3) a resistance training group (60-80% baseline maximum load achieved in one repetition); and (4) a combined aerobic exercise plus resistance training group, as in groups 2 and 3. All participants had HbA(1c) levels ≥ 48 mmol/mol (≥ 6.5%), without overt diabetic vascular complications. Blood samples, clinical characteristics, peak oxygen uptake and carotid intima-media thickness measurements were obtained at baseline and at the end of the study, after 6 months.RESULTSAt baseline, there were non-significant differences between groups. All active groups significantly ameliorated glycaemic profile, insulin sensitivity and triglycerides levels compared with the control group (P < 0.05). Aerobic training further improved lipids, systolic blood pressure and exercise capacity compared with the resistance training and the control groups (P < 0.05). Moreover, high-sensitivity C-reactive protein and visfatin decreased, while vaspin and apelin circulating levels increased within the aerobic exercise group and the aerobic exercise plus resistance training group, and compared with the other groups (P < 0.05). Within- and between-group comparisons showed negligible alterations in ghrelin serum levels and body weight after all exercise modalities. Finally, aerobic training attenuated the carotid intima-media thickness progression (0.017 ± 0.006 mm) compared with the control subjects (0.129 ± 0.042 mm, P < 0.001). That effect was independently associated with visfatin and amelioration of peak oxygen uptake.CONCLUSIONSIn subjects with Type 2 diabetes, all exercise training modalities improved metabolic profile. Importantly, aerobic training predominantly ameliorated adipokines concentrations and carotid intima-media thickness progression. |
Author | Kapelouzou, A. Liapis, C. D. Vrabas, I. S. Fotiadis, G. Kadoglou, N. P. E. Kostakis, A. |
Author_xml | – sequence: 1 givenname: N. P. E. surname: Kadoglou fullname: Kadoglou, N. P. E. email: nikoskad@yahoo.com organization: Department of Physical Education and Sports Science at Serres, Aristotle University of Thessaloniki – sequence: 2 givenname: G. surname: Fotiadis fullname: Fotiadis, G. organization: First Department of Internal Medicine, 'Hippokratio' General Hospital of Thessaloniki, Thessaloniki – sequence: 3 givenname: A. surname: Kapelouzou fullname: Kapelouzou, A. organization: Center of Experimental Surgery, Biomedical Research FoundationAcademy of Athens – sequence: 4 givenname: A. surname: Kostakis fullname: Kostakis, A. organization: Center of Experimental Surgery, Biomedical Research FoundationAcademy of Athens – sequence: 5 givenname: C. D. surname: Liapis fullname: Liapis, C. D. organization: Department of Vascular Surgery, University of Athens, Athens, Greece – sequence: 6 givenname: I. S. surname: Vrabas fullname: Vrabas, I. S. organization: Department of Physical Education and Sports Science at Serres, Aristotle University of Thessaloniki |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23078531$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kcFu1DAURS1URKeFBT-ALLGBRVrbsZN4iUoZkFpAYoCl5dgvjEsSD7ZHbf6GJd_Bl-GQtgskvPCT7HOv7tM9QgejHwGhp5Sc0HxO7QAnlBEhHqAV5RUvBJf0AK1IzVlRkpoeoqMYrwihTJbyETpk-bERJV2hX5stYOu6DgKMyeke6zwKN3a9HgadfJgw5F-TIvYdhhsIxkXAg7e6d8lBzAKL0xZcwDpGb5xOzo_42qUtBh36CRsdfHIW60wFH00_3y7iXfDfAsQ4427EuyzMGeIi3Uw7-P2T5Wy6hQTxMXrY6T7Ck9t5jD6_Od-cvS0uPqzfnb26KEwpqSiElLyzhFS04rypQBvgtOksM7StWsOYFgAcam7aqqlEQ0sKxAIXkljNG14eoxeLb073Yw8xqcFFA32vR_D7qCiry7ohjSwz-vwf9Mrvw5jTzRSta8nq2fDlQpm8dQzQqV1wgw6TokTN9alcn_pbX2af3Tru2wHsPXnXVwZOF-Da9TD930m9vjy_sywWhYsJbu4VOnxXVd5EqK_v12pNv3wUl58aJcs_EcO5EA |
CODEN | DIMEEV |
CitedBy_id | crossref_primary_10_1016_j_numecd_2021_02_030 crossref_primary_10_1186_s13102_024_00915_4 crossref_primary_10_1002_jcp_28420 crossref_primary_10_1007_s40279_015_0379_7 crossref_primary_10_1080_17446651_2018_1416290 crossref_primary_10_3390_healthcare11040594 crossref_primary_10_1007_s11154_021_09657_x crossref_primary_10_1007_s40279_013_0128_8 crossref_primary_10_1123_japa_2019_0150 crossref_primary_10_1016_j_clinthera_2017_05_001 crossref_primary_10_1136_bjsports_2016_095999 crossref_primary_10_14814_phy2_15674 crossref_primary_10_23736_S0022_4707_23_15263_7 crossref_primary_10_3390_jfmk7020048 crossref_primary_10_3389_fendo_2023_1216962 crossref_primary_10_1515_tjb_2020_0014 crossref_primary_10_1111_bph_12399 crossref_primary_10_1016_j_cca_2013_09_001 crossref_primary_10_1016_j_dsx_2016_06_017 crossref_primary_10_1016_j_physbeh_2022_113888 crossref_primary_10_5812_asjsm_57690 crossref_primary_10_3390_antiox12081488 crossref_primary_10_1007_s00424_022_02702_x crossref_primary_10_1113_EP087005 crossref_primary_10_2147_DMSO_S438344 crossref_primary_10_1016_j_apunts_2015_05_001 crossref_primary_10_1016_j_cyto_2023_156157 crossref_primary_10_1002_jcsm_12926 crossref_primary_10_7717_peerj_17525 crossref_primary_10_4239_wjd_v14_i5_565 crossref_primary_10_1016_j_cyto_2020_155364 crossref_primary_10_1590_s1980_6574201800020006 crossref_primary_10_1002_tsm2_294 crossref_primary_10_1515_tjb_2021_0023 crossref_primary_10_1007_s00421_014_3016_5 crossref_primary_10_1371_journal_pone_0296815 crossref_primary_10_1016_j_archger_2024_105530 crossref_primary_10_1016_j_gene_2018_04_003 crossref_primary_10_1186_s43162_023_00247_8 crossref_primary_10_1007_s11892_017_0927_7 crossref_primary_10_1016_j_jdiacomp_2019_107469 crossref_primary_10_1186_s40798_019_0194_z crossref_primary_10_4093_dmj_2023_0112 crossref_primary_10_1038_s41598_020_67004_7 crossref_primary_10_1186_s12905_019_0722_5 crossref_primary_10_2478_prilozi_2021_0010 crossref_primary_10_3390_ijerph20031783 crossref_primary_10_1097_PHM_0000000000001002 crossref_primary_10_3389_fphys_2023_1252052 crossref_primary_10_1007_s00125_014_3303_z crossref_primary_10_1152_japplphysiol_00247_2020 crossref_primary_10_1016_j_jshs_2022_11_003 crossref_primary_10_1097_MD_0000000000031861 crossref_primary_10_1007_s11332_018_0462_1 crossref_primary_10_1139_apnm_2015_0693 crossref_primary_10_1155_2017_8523728 crossref_primary_10_1007_s13105_017_0602_0 crossref_primary_10_1007_s42000_019_00157_x crossref_primary_10_1016_j_exger_2019_01_003 crossref_primary_10_1007_s11332_015_0225_1 crossref_primary_10_1111_obr_13564 crossref_primary_10_1161_JAHA_114_000828 crossref_primary_10_3390_healthcare11030440 crossref_primary_10_3390_ph16101396 crossref_primary_10_1111_obr_13007 crossref_primary_10_3389_fendo_2022_820002 crossref_primary_10_4236_health_2017_912118 crossref_primary_10_1038_ijo_2013_158 crossref_primary_10_1177_15598276231180541 crossref_primary_10_3390_healthcare10061098 crossref_primary_10_1016_j_exger_2023_112310 crossref_primary_10_1016_j_bjpt_2017_06_004 crossref_primary_10_1111_sms_12495 crossref_primary_10_3390_ijerph20032189 crossref_primary_10_3389_fphys_2019_00656 crossref_primary_10_1007_s11332_013_0157_6 crossref_primary_10_1113_EP089371 crossref_primary_10_1007_s13410_015_0329_9 crossref_primary_10_1089_met_2013_0054 crossref_primary_10_3390_biomedicines11051290 crossref_primary_10_4093_dmj_2022_0007 crossref_primary_10_1007_s40279_014_0226_2 crossref_primary_10_1186_s12933_016_0336_2 crossref_primary_10_1016_j_scispo_2022_11_003 crossref_primary_10_2147_DMSO_S247351 crossref_primary_10_14814_phy2_14823 crossref_primary_10_17795_ajnpp_34440 crossref_primary_10_3390_nu15061539 crossref_primary_10_1016_j_jsams_2024_03_007 crossref_primary_10_5763_kjsm_2020_38_3_155 crossref_primary_10_1177_1479164115588548 crossref_primary_10_3390_nu11102432 crossref_primary_10_3390_ijerph192214928 crossref_primary_10_1123_jpah_2022_0372 |
Cites_doi | 10.1016/j.metabol.2006.03.017 10.1016/B978-0-12-385061-4.00008-8 10.1111/j.1463-1326.2008.00872.x 10.1111/j.1365-2265.2011.04135.x 10.2337/dc12-s011 10.1016/j.metabol.2011.01.006 10.2337/db07-1045 10.1155/2012/941868 10.1007/s00125-010-2042-z 10.1111/j.1467-789X.2010.00776.x 10.2165/11531380-000000000-00000 10.1002/dmrr.1201 10.1016/j.regpep.2011.05.008 10.1016/j.cca.2010.09.012 10.1249/MSS.0b013e31824526cc 10.1097/HJH.0b013e328344da76 10.2337/diacare.24.1.117 10.1517/13543784.17.3.327 10.1016/j.ejim.2011.10.020 10.1097/HJR.0b013e3282efaf50 10.1007/BF03165767 10.1001/jama.2010.1710 10.2217/bmm.10.79 10.1016/j.trsl.2010.01.004 10.1055/s-0029-1237360 10.1016/j.amjcard.2009.03.027 10.1007/s11695-009-9955-y 10.1016/j.coph.2005.10.006 10.1016/j.ejvs.2007.08.022 10.1016/j.numecd.2009.04.015 |
ContentType | Journal Article |
Copyright | 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK. Diabetic Medicine © 2013 Diabetes UK |
Copyright_xml | – notice: 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK – notice: 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK. – notice: Diabetic Medicine © 2013 Diabetes UK |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 8FD FR3 H94 K9. P64 RC3 7X8 |
DOI | 10.1111/dme.12055 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Immunology Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Genetics Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | Genetics Abstracts MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Nursing |
EISSN | 1464-5491 |
EndPage | e50 |
ExternalDocumentID | 2870911751 10_1111_dme_12055 23078531 DME12055 ark_67375_WNG_G1VP5MS8_9 |
Genre | article Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 29F 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD ESX EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RWI RX1 SAMSI SUPJJ TEORI UB1 V8K V9Y W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 XV2 YFH YUY ZGI ZXP ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7T5 8FD FR3 H94 K9. P64 RC3 7X8 |
ID | FETCH-LOGICAL-c3915-5994fd006164486eace418fd2c1b6bc22a5ee4e74cb68658131e0de4590da4843 |
IEDL.DBID | DR2 |
ISSN | 0742-3071 |
IngestDate | Fri Aug 16 22:25:03 EDT 2024 Thu Oct 10 19:41:05 EDT 2024 Fri Aug 23 00:54:51 EDT 2024 Sat Sep 28 08:07:43 EDT 2024 Sat Aug 24 00:49:48 EDT 2024 Wed Oct 30 09:51:02 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3915-5994fd006164486eace418fd2c1b6bc22a5ee4e74cb68658131e0de4590da4843 |
Notes | ArticleID:DME12055 istex:3CDB4A62F045211003637E99525092CEDBD93E48 ark:/67375/WNG-G1VP5MS8-9 Clinical Trials Registry No; NCT 00636766 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 ObjectType-Feature-3 content type line 23 |
PMID | 23078531 |
PQID | 1271779274 |
PQPubID | 1006515 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1273780893 proquest_journals_1271779274 crossref_primary_10_1111_dme_12055 pubmed_primary_23078531 wiley_primary_10_1111_dme_12055_DME12055 istex_primary_ark_67375_WNG_G1VP5MS8_9 |
PublicationCentury | 2000 |
PublicationDate | 2013-02 February 2013 2013-Feb 2013-02-00 20130201 |
PublicationDateYYYYMMDD | 2013-02-01 |
PublicationDate_xml | – month: 02 year: 2013 text: 2013-02 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Diabetic medicine |
PublicationTitleAlternate | Diabet. Med |
PublicationYear | 2013 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin Investig Drugs 2008; 17: 327-333. Kadoglou NP, Iliadis F, Liapis CD. Exercise and carotid atherosclerosis. Eur J Vasc Endovasc Surg 2008; 35: 264-272. Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome, and cardiovascular diseases: a meta-analysis and systemic review. Diabetes Metab Res Rev 2011; 27: 515-527. Soriguer F, Garrido-Sanchez L, Garcia-Serrano S, Garcia-Almeida JM, Garcia-Arnes J, Tinahones FJ et al. Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus. Obes Surg 2009; 19: 1574-1580. Przewlocka-Kosmala M, Kotwica T, Mysiak A, Kosmala W. Reduced circulating apelin in essential hypertension and its association with cardiac dysfunction. J Hypertens 2011; 29: 971-979. Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P et al. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis 2010; 20: 608-617. Swift DL, Johannsen NM, Earnest CP, Blair SN, Church TS. Effect of exercise training modality on C-reactive protein in type 2 diabetes. Med Sci Sports Exerc 2012; 44: 1028-1034. Jorge ML, de Oliveira VN, Resende NM, Paraiso LF, Calixto A, Diniz AL et al. The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus. Metabolism 2011; 60: 1244-1252. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012; 35: S11-S63. Kadoglou NP, Sailer N, Moumtzouoglou A, Kapelouzou A, Tsanikidis H, Vitta I et al. Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 2010; 118: 75-80. Friebe D, Neef M, Kratzsch J, Erbs S, Dittrich K, Garten A et al. Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia 2011; 54: 1200-1211. Cederberg H, Koivisto VM, Jokelainen J, Surcel HM, Keinänen-Kiukaanniemi S, Rajala U. Unacylated ghrelin is associated with changes in insulin sensitivity and lipid profile during an exercise intervention. Clin Endocrinol (Oxf) 2012; 76: 39-45. Kadoglou NP, Iliadis F, Angelopoulou N, Perrea D, Ampatzidis G, Liapis CD et al. The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil 2007; 14: 837-843. Carpéné C, Dray C, Attané C, Valet P, Portillo MP, Churruca I et al. Expanding role for the apelin/APJ system in physiopathology. J Physiol Biochem 2007; 63: 359-373. Church TS, Blair SN, Cocreham S, Johannsen N, Johnson W, Kramer K et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. J Am Med Assoc 2010; 304: 2253-2262. Arsenault BJ, Cartier A, Côté M, Lemieux I, Tremblay A, Bouchard C et al. Body composition, cardiorespiratory fitness, and low-grade inflammation in middle-aged men and women. Am J Cardiol 2009; 104: 240-246. Srtasser B, Siebert U, Schobersberger W. Resistance training in the treatment of the metabolic syndrome: a systematic review and meta-analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism. Sports Med 2010; 40: 397-415. Wing RR, Goldstein MG, Acton KJ, Birch LL, Jakicic JM, Sallis JF et al. Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care 2001; 24: 117-123. García EA, Korbonits M. Ghrelin and cardiovascular health. Curr Opin Pharmacol 2006; 6: 142-147. Kadoglou NP, Lampropoulos S, Kapelouzou A, Gkontopoulos A, Theofilogiannakos EK, Fotiadis G et al. Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease-Kozani Study. Transl Res 2010; 155: 238-246. Xu A, Wang Y, Lam KS, Vanhoutte PM. Vascular actions of adipokines molecular mechanisms and therapeutic implications. Adv Pharmacol 2010; 60: 229-255. Kadoglou NP, Avgerinos ED, Liapis CD. An update on markers of carotid atherosclerosis in patients with Type 2 diabetes. Biomark Med 2010; 4: 601-609. Golbidi S, Badran M, Laher I. Antioxidant and anti-inflammatory effects of exercise in diabetic patients. Exp Diabetes Res 2012; 2012: 941868. Brema I, Hatunic M, Finucane F, Burns N, Nolan JJ, Haider D et al. Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes Obes Metab 2008; 10: 600-602. Adams CE, Greenway FL, Brantley PJ. Lifestyle factors and ghrelin: critical review and implications for weight loss maintenance. Obes Rev 2011; 12: e211-e218. Kadoglou NP, Vrabas IS, Kapelouzou A, Lampropoulos S, Sailer N, Kostakis A et al. Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk. Regul Pept 2011; 170: 57-61. Kadoglou NP, Gkontopoulos A, Kapelouzou A, Fotiadis G, Theofilogiannakos EK, Kottas G et al. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. Clin Chim Acta 2011; 412: 48-52. Kadoglou NP, Vrabas IS, Kapelouzou A, Angelopoulou N. The association of physical activity with novel adipokines in patients with type 2 diabetes. Eur J Intern Med 2012; 23: 137-142. Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes 2008; 57: 372-377. Kim SH, Lee SJ, Kang ES, Kang S, Hur KY, Lee HJ et al. Effects of lifestyle modification on metabolic parameters and carotid intima-media thickness in patients with type 2 diabetes mellitus. Metabolism 2006; 55: 1053-1059. 2011; 412 2012; 2012 2010; 304 2006; 55 2011; 60 2008; 17 2006; 6 2011; 54 2008; 57 2008; 35 2008; 10 2011; 170 2011; 12 2012; 35 2001; 24 2012; 76 2010; 40 2007; 14 2010; 60 2010; 20 2010; 118 2010; 155 2007; 63 2011; 27 2009; 19 2012; 23 2010; 4 2012; 44 2011; 29 2009; 104 e_1_2_5_27_1 e_1_2_5_28_1 e_1_2_5_25_1 e_1_2_5_26_1 e_1_2_5_23_1 e_1_2_5_24_1 e_1_2_5_21_1 e_1_2_5_22_1 e_1_2_5_29_1 e_1_2_5_20_1 e_1_2_5_15_1 e_1_2_5_14_1 e_1_2_5_17_1 e_1_2_5_9_1 e_1_2_5_16_1 e_1_2_5_8_1 e_1_2_5_11_1 e_1_2_5_7_1 e_1_2_5_10_1 e_1_2_5_6_1 e_1_2_5_13_1 e_1_2_5_5_1 e_1_2_5_12_1 e_1_2_5_4_1 e_1_2_5_3_1 e_1_2_5_2_1 e_1_2_5_19_1 e_1_2_5_18_1 e_1_2_5_30_1 e_1_2_5_31_1 |
References_xml | – volume: 76 start-page: 39 year: 2012 end-page: 45 article-title: Unacylated ghrelin is associated with changes in insulin sensitivity and lipid profile during an exercise intervention publication-title: Clin Endocrinol (Oxf) – volume: 155 start-page: 238 year: 2010 end-page: 246 article-title: Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease—Kozani Study publication-title: Transl Res – volume: 40 start-page: 397 year: 2010 end-page: 415 article-title: Resistance training in the treatment of the metabolic syndrome: a systematic review and meta‐analysis of the effect of resistance training on metabolic clustering in patients with abnormal glucose metabolism publication-title: Sports Med – volume: 4 start-page: 601 year: 2010 end-page: 609 article-title: An update on markers of carotid atherosclerosis in patients with Type 2 diabetes publication-title: Biomark Med – volume: 14 start-page: 837 year: 2007 end-page: 843 article-title: The anti‐inflammatory effects of exercise training in patients with type 2 diabetes mellitus publication-title: Eur J Cardiovasc Prev Rehabil – volume: 104 start-page: 240 year: 2009 end-page: 246 article-title: Body composition, cardiorespiratory fitness, and low‐grade inflammation in middle‐aged men and women publication-title: Am J Cardiol – volume: 35 start-page: S11 year: 2012 end-page: S63 article-title: Standards of medical care in diabetes—2012 publication-title: Diabetes Care – volume: 304 start-page: 2253 year: 2010 end-page: 2262 article-title: Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial publication-title: J Am Med Assoc – volume: 118 start-page: 75 year: 2010 end-page: 80 article-title: Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes publication-title: Exp Clin Endocrinol Diabetes – volume: 19 start-page: 1574 year: 2009 end-page: 1580 article-title: Apelin levels are increased in morbidly obese subjects with type 2 diabetes mellitus publication-title: Obes Surg – volume: 23 start-page: 137 year: 2012 end-page: 142 article-title: The association of physical activity with novel adipokines in patients with type 2 diabetes publication-title: Eur J Intern Med – volume: 20 start-page: 608 year: 2010 end-page: 617 article-title: Anti‐inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss publication-title: Nutr Metab Cardiovasc Dis – volume: 63 start-page: 359 year: 2007 end-page: 373 article-title: Expanding role for the apelin/APJ system in physiopathology publication-title: J Physiol Biochem – volume: 54 start-page: 1200 year: 2011 end-page: 1211 article-title: Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre‐B cell colony (PBEF)/visfatin linking obesity and inflammation in humans publication-title: Diabetologia – volume: 57 start-page: 372 year: 2008 end-page: 377 article-title: Serum vaspin concentrations in human obesity and type 2 diabetes publication-title: Diabetes – volume: 12 start-page: e211 year: 2011 end-page: e218 article-title: Lifestyle factors and ghrelin: critical review and implications for weight loss maintenance publication-title: Obes Rev – volume: 60 start-page: 229 year: 2010 end-page: 255 article-title: Vascular actions of adipokines molecular mechanisms and therapeutic implications publication-title: Adv Pharmacol – volume: 412 start-page: 48 year: 2011 end-page: 52 article-title: Serum levels of vaspin and visfatin in patients with coronary artery disease—Kozani study publication-title: Clin Chim Acta – volume: 44 start-page: 1028 year: 2012 end-page: 1034 article-title: Effect of exercise training modality on C‐reactive protein in type 2 diabetes publication-title: Med Sci Sports Exerc – volume: 60 start-page: 1244 year: 2011 end-page: 1252 article-title: The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus publication-title: Metabolism – volume: 29 start-page: 971 year: 2011 end-page: 979 article-title: Reduced circulating apelin in essential hypertension and its association with cardiac dysfunction publication-title: J Hypertens – volume: 55 start-page: 1053 year: 2006 end-page: 1059 article-title: Effects of lifestyle modification on metabolic parameters and carotid intima‐media thickness in patients with type 2 diabetes mellitus publication-title: Metabolism – volume: 27 start-page: 515 year: 2011 end-page: 527 article-title: Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome, and cardiovascular diseases: a meta‐analysis and systemic review publication-title: Diabetes Metab Res Rev – volume: 24 start-page: 117 year: 2001 end-page: 123 article-title: Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity publication-title: Diabetes Care – volume: 10 start-page: 600 year: 2008 end-page: 602 article-title: Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus publication-title: Diabetes Obes Metab – volume: 35 start-page: 264 year: 2008 end-page: 272 article-title: Exercise and carotid atherosclerosis publication-title: Eur J Vasc Endovasc Surg – volume: 170 start-page: 57 year: 2011 end-page: 61 article-title: Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk publication-title: Regul Pept – volume: 17 start-page: 327 year: 2008 end-page: 333 article-title: Vaspin: a novel serpin with insulin‐sensitizing effects publication-title: Expert Opin Investig Drugs – volume: 6 start-page: 142 year: 2006 end-page: 147 article-title: Ghrelin and cardiovascular health publication-title: Curr Opin Pharmacol – volume: 2012 start-page: 941868 year: 2012 article-title: Antioxidant and anti‐inflammatory effects of exercise in diabetic patients publication-title: Exp Diabetes Res – ident: e_1_2_5_30_1 doi: 10.1016/j.metabol.2006.03.017 – ident: e_1_2_5_6_1 doi: 10.1016/B978-0-12-385061-4.00008-8 – ident: e_1_2_5_21_1 doi: 10.1111/j.1463-1326.2008.00872.x – ident: e_1_2_5_28_1 doi: 10.1111/j.1365-2265.2011.04135.x – ident: e_1_2_5_2_1 doi: 10.2337/dc12-s011 – ident: e_1_2_5_20_1 doi: 10.1016/j.metabol.2011.01.006 – ident: e_1_2_5_24_1 doi: 10.2337/db07-1045 – ident: e_1_2_5_19_1 doi: 10.1155/2012/941868 – ident: e_1_2_5_22_1 doi: 10.1007/s00125-010-2042-z – ident: e_1_2_5_27_1 doi: 10.1111/j.1467-789X.2010.00776.x – ident: e_1_2_5_3_1 doi: 10.2165/11531380-000000000-00000 – ident: e_1_2_5_7_1 doi: 10.1002/dmrr.1201 – ident: e_1_2_5_26_1 doi: 10.1016/j.regpep.2011.05.008 – ident: e_1_2_5_12_1 doi: 10.1016/j.cca.2010.09.012 – ident: e_1_2_5_18_1 doi: 10.1249/MSS.0b013e31824526cc – ident: e_1_2_5_23_1 doi: 10.1097/HJH.0b013e328344da76 – ident: e_1_2_5_31_1 doi: 10.2337/diacare.24.1.117 – ident: e_1_2_5_11_1 doi: 10.1517/13543784.17.3.327 – ident: e_1_2_5_16_1 doi: 10.1016/j.ejim.2011.10.020 – ident: e_1_2_5_5_1 doi: 10.1097/HJR.0b013e3282efaf50 – ident: e_1_2_5_9_1 doi: 10.1007/BF03165767 – ident: e_1_2_5_4_1 doi: 10.1001/jama.2010.1710 – ident: e_1_2_5_14_1 doi: 10.2217/bmm.10.79 – ident: e_1_2_5_10_1 doi: 10.1016/j.trsl.2010.01.004 – ident: e_1_2_5_15_1 doi: 10.1055/s-0029-1237360 – ident: e_1_2_5_25_1 doi: 10.1016/j.amjcard.2009.03.027 – ident: e_1_2_5_8_1 doi: 10.1007/s11695-009-9955-y – ident: e_1_2_5_13_1 doi: 10.1016/j.coph.2005.10.006 – ident: e_1_2_5_29_1 doi: 10.1016/j.ejvs.2007.08.022 – ident: e_1_2_5_17_1 doi: 10.1016/j.numecd.2009.04.015 |
SSID | ssj0012939 |
Score | 2.4369082 |
Snippet | Objective
Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different... Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different exercise... Abstract Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of... Objective Adipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different... OBJECTIVEAdipokines, visfatin, apelin, vaspin and ghrelin have emerged as novel cardiovascular risk factors. We aimed to evaluate the effects of different... |
SourceID | proquest crossref pubmed wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | e41 |
SubjectTerms | Adipokines - metabolism Analysis of Variance Anti-Inflammatory Agents - metabolism Apelin Blood Glucose - metabolism Cardiovascular disease Carotid Artery Diseases - blood Carotid Artery Diseases - physiopathology Carotid Artery Diseases - prevention & control Carotid Intima-Media Thickness Diabetes Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - metabolism Diabetes Mellitus, Type 2 - physiopathology Diabetes Mellitus, Type 2 - therapy Diabetic Angiopathies - blood Diabetic Angiopathies - physiopathology Diabetic Angiopathies - therapy Diet Disease Progression Exercise Fasting Female Ghrelin - metabolism Glycated Hemoglobin A - metabolism Humans Insulin Resistance Intercellular Signaling Peptides and Proteins - metabolism Male Middle Aged Nicotinamide Phosphoribosyltransferase - metabolism Physical fitness Resistance Training Risk Factors Serpins - metabolism |
Title | The differential anti-inflammatory effects of exercise modalities and their association with early carotid atherosclerosis progression in patients with Type 2 diabetes |
URI | https://api.istex.fr/ark:/67375/WNG-G1VP5MS8-9/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fdme.12055 https://www.ncbi.nlm.nih.gov/pubmed/23078531 https://www.proquest.com/docview/1271779274 https://search.proquest.com/docview/1273780893 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NitRAEC6WFcWLq6uuWVcpRcRLhnSmO0njSdw_hFlEXd2DEDrpDgzrJLKZAfHkI_gInn0MH8UnsarzoysK4mUYmO6kp_NV-qvq6q8AHmSsYe4yE5pCuVBmiQu1ky6MpikzXqejig8nz46Sw2P57ESdrMHj4SxMpw8xBtzYMvz7mg3cFO0vRm4XbiLiSPEBczFNOZ1r98UoHcXLmO4kOGOOr4heVYizeMae59aiCzytH_5ENM_zVr_w7G_A22HIXb7J6WS1LCblx9_UHP_zP12FKz0hxScdgq7Bmqs34dKs33LfhIt9POE6fCVI4VBQhV4M75Ceyvz7p88EUsLVwu_XY58ggk2FQzknXDSW6T455dTFot-cQPMTGMjRYHSstYxcR2g5t-iZadPSmOhz3qJPJOtERHBeY68H23Zd2Zv-9iXGIZJ8A4739149PQz7Ug9hyQr1odJaVpb5FPuLCa0GToqssnEpiqQo49goRxBKZVkkGZEmMRUusk4qHVkjMzm9Cet1U7tbgMRZtTHSpK4S0uhSF1aUTsuokpmKjA3g_vDQ8_edokc-eEI0_7mf_wAeejiMLczZKafApSp_c3SQH4jXz9XsZZbrAHYGvOS99bd0CXKSU00OfwD3xp_JbnkzxtSuWfk2BNqI6GIAWx3Oxptxcj7RKBHAI4-Wv48z353t-S_b_970NlyOfU0PzsnZgfXl2crdIWa1LO56E_oBH-cipQ |
link.rule.ids | 315,783,787,1378,27936,27937,46306,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VVlAu_BQogQIGIcQlqzixk1jigujPAs0KQQu9oMiJHWlVNkHdXQlx4hF4BM48Bo_CkzDj_EARSIjLaqW1E6_zjf3NePINwP2UNMxtqn1dSOuLNLa-ssL6QZQQ47UqqOjl5GwSjw_FsyN5tAKP-ndhWn2IIeBGluHWazJwCkj_YuVmZkc8DKQ8A2to7hEVbth-OYhH0UamWhHOkCIsvNMVojyeoeup3WiNJvbDn6jmaebqtp7di_C2H3SbcXI8Wi6KUfnxNz3H__1Xl-BCx0nZ4xZEl2HF1htwLutO3TfgbBdSuAJfEVWsr6mCa8M7hg9m-v3TZ8QpQmvmjuxZlyPCmor1FZ3YrDHE-NEvxy6GufMJpn9ig1FAmFmSW2ZUSmgxNcyR02aOY8LP6Zy5XLJWR4RNa9ZJws7bruRQf_sSsj6YfBUOd3cOnoz9rtqDX5JIvS-VEpUhSkUuY4wbghU8rUxY8iIuyjDU0iKKElEWcYq8iUfcBsYKqQKjRSqia7BaN7W9Dgxpq9Ja6MRWXGhVqsLw0ioRVCKVgTYe3Oufev6-FfXIe2cI5z938-_BA4eHoYU-OaYsuETmbyZ7-R5__UJmr9JcebDVAybvFoA5XgL95EShz-_B3eFnNF06j9G1bZauTZSkATJGDzZboA03o_x8ZFLcg4cOLn8fZ76d7bgvN_696R1YHx9k-_n-08nzm3A-dCU-KEVnC1YXJ0t7C4nWorjt7OkHFpomvQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwEB2VVlR94VIuDRQwCCFesoqzdhKLJ0S7LZddVUChD0iWEzvSqmxSdXclxBOfwCfwzGfwKXwJM84FikBCvEQrxU68zpn4zHhyBuB-RhrmLjOhyaULRZa4UDnhwmiYEuN1Kirp4-TxJNk_FM-O5NEKPOq-hWn0IfqAG1mGf1-TgZ_Y8hcjtzM34HEk5TlYEwkyX2JEL3vtKFrHVKPBGVOAhbeyQpTG03c9sxit0bx--BPTPEtc_cozugjvujE3CSfHg-UiHxQff5Nz_M8_dQkutIyUPW4gdBlWXLUJ6-N2z30TzrcBhSvwFTHFuooq-GZ4z_CxTL9_-owoRWDN_IY9azNEWF2yrp4Tm9WW-D565djFMr87wcxPZDAKBzNHYsuMCgktppZ5alrPcUx4nM6ZzyRrVETYtGKtIOy86Uru9LcvMetCyVfhcLT7-sl-2NZ6CAuSqA-lUqK0RKjIYUxwOXCCZ6WNC54neRHHRjrEUCqKPMmQNfEhd5F1QqrIGpGJ4TVYrerKbQFD0qqMESZ1JRdGFSq3vHBKRKXIZGRsAPe6h65PGkkP3blCOP_az38ADzwc-hbm9Jhy4FKp30729B5_cyDHrzKtAtju8KJb85_jJdBLThV6_AHc7U-j4dJujKlcvfRthmkWIV8M4HqDs_5mlJ2PPIoH8NCj5e_j1DvjXf_jxr83vQPrBzsj_eLp5PlN2Ih9fQ_Kz9mG1cXp0t1ClrXIb3tr-gGTOSVs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+differential+anti%E2%80%90inflammatory+effects+of+exercise+modalities+and+their+association+with+early+carotid+atherosclerosis+progression+in+patients+with+Type%C2%A02+diabetes&rft.jtitle=Diabetic+medicine&rft.au=Kadoglou%2C+N.+P.+E.&rft.au=Fotiadis%2C+G.&rft.au=Kapelouzou%2C+A.&rft.au=Kostakis%2C+A.&rft.date=2013-02-01&rft.issn=0742-3071&rft.eissn=1464-5491&rft.volume=30&rft.issue=2&rft_id=info:doi/10.1111%2Fdme.12055&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_dme_12055 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0742-3071&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0742-3071&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0742-3071&client=summon |